Illumina, Pacific Biosciences abandon $1.2B merger over FTC opposition Jan. 3, 2020 By Mark McCarty No Comments Two players in the gene sequencing space, Illumina Inc. and Pacific Biosciences, have scotched their planned $1.2 billion merger roughly two weeks after the U.S. Federal Trade Commission posted a 5-0 vote to seek an injunction against the merger. Read More